PULMONX CORPORATION (LUNG) Operating income 2018–2025
PULMONX CORPORATION (LUNG) annual operating income history from SEC filings — each fiscal year as reported.
-$53.7MFY2025 · since FY2018: -$15.1M → -$53.7M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$53.7M | +7.0% |
| FY2024 | -$57.7M | +6.8% |
| FY2023 | -$61.9M | -5.6% |
| FY2022 | -$58.6M | -24.0% |
| FY2021 | -$47.3M | -46.3% |
| FY2020 | -$32.3M | -81.3% |
| FY2019 | -$17.8M | -18.5% |
| FY2018 | -$15.1M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More LUNG financial trends
LUNG RevenueLUNG Net incomeLUNG Net marginLUNG Gross profitLUNG Gross marginLUNG Operating marginLUNG Operating cash flowLUNG Free cash flowLUNG Capital expendituresLUNG Return on equityLUNG Stock buybacksLUNG Dividends paidLUNG Total assetsLUNG Total liabilitiesLUNG Shareholders’ equityLUNG overview →